Ruling Protects North Carolina Homebuyers from Predatory Contracts
PR Newswire
Today at 12:36pm UTC
Streamex Announces Official Launch Date of GLDY, a Yield Bearing Gold-Backed Tokenized Security
GlobeNewswire
Today at 12:31pm UTC
JLL Reports 2025 Financial Results for Fourth Quarter and Full Year
PR Newswire
Today at 12:30pm UTC
Nexxen to Announce Fourth Quarter 2025 Financial Results on March 4, 2026
GlobeNewswire
Today at 12:30pm UTC
Southeast U.S. Leader Judge PR Launches AI-Powered Marketing Service - Backed by a Creative Team with 20+ Emmy Awards - to Dominate Google,...
PR Newswire
Today at 12:30pm UTC
Exco Technologies Limited Announces Normal Course Issuer Bid
GlobeNewswire
Today at 12:30pm UTC
First Patients Dosed in Alphyn Biologics' Phase 2 Trial of First-in-Class Topical Therapeutic for Molluscum Contagiosum
PR Newswire
Today at 12:30pm UTC
BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to...
GlobeNewswire
Today at 12:30pm UTC
Osteria da Fortunata continues to strengthen its presence in Miami Beach more than two years after opening
PR Newswire
Today at 12:30pm UTC
General Counsel Report Finds Legal Leaders Facing Increased Complexity, Unpredictability, Regulatory Activity and Costs
GlobeNewswire
Today at 12:30pm UTC
Nova to Participate in Upcoming Investor Conferences
PR Newswire
Today at 12:30pm UTC
Nayax Announces Global Partnership with DC Fast Charger OEM Tritium to Simplify EV Charger Payment Enablement
GlobeNewswire
Today at 12:30pm UTC
HUMAIN Backs xAI with $3 Billion Series E Investment Ahead of Historic SpaceX Merger
PR Newswire
Today at 12:30pm UTC
ModelOp Appoints Dave Trier to CEO As It Enters Next Phase of Growth
GlobeNewswire
Today at 12:30pm UTC
V2X Awarded ATSP5 Contract to Advance Emerging Technology for the Warfighter
PR Newswire
Today at 12:30pm UTC
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
GlobeNewswire
Today at 12:30pm UTC
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head...
PR Newswire
Today at 12:30pm UTC
Creative Realities Announces Repurchase of Slipstream Warrants
GlobeNewswire
Today at 12:30pm UTC
LAZARD EXPANDS ITS HEALTHCARE SERVICES TEAM WITH ADDITION OF JOHN KOSKI AND ROBERT LOWE
PR Newswire
Today at 12:30pm UTC
Medicenna Therapeutics Announces Participation in Upcoming Conferences
GlobeNewswire
Today at 12:30pm UTC
  • <
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 19
  • 20
  • >
  • About
  • Staff
  • Contact
  • Media Kit
  • Real Estate
  • Post an Obituary
  • ASU NEWSWELL
  • Facebook
  • Twitter
  • Instagram
  • RSS
Times of San Diego
  • DONATE
  • NEWSLETTER
  • All topics
    • Arts
    • Business
    • Crime
    • Education
    • Events
    • Health
    • Life
    • Military
    • Obituaries
    • Opinion
    • Politics
    • Press Releases
    • Sports
    • Tech
  • Home
  • Beach & Bay
  • Downtown News
  • La Jolla
  • La Mesa Courier
  • Mission Times
  • Peninsula Beacon
  • Uptown News
Times of San Diego
  • Facebook
  • Twitter
  • Instagram
  • RSS

ABOUT
Donate
Newsletters
Corrections policy
Contact us
Advertising and sponsorship policies
Reader submission guidelines and form
Privacy statement
Republication guidelines
Additional policies and guidelines
Terms of use
Donor transparency

Support Local News

San Diego residents need the truth. Help us report it. Join the growing list of donors investing in our community's long-term future. 

DONATE
© 2025 NEWSWELL Powered by Newspack